1. Home
  2. TECX vs RGR Comparison

TECX vs RGR Comparison

Compare TECX & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$34.54

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Logo Sturm Ruger & Company Inc.

RGR

Sturm Ruger & Company Inc.

HOLD

Current Price

$38.57

Market Cap

617.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
RGR
Founded
2019
1949
Country
United States
United States
Employees
60
N/A
Industry
Ordnance And Accessories
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
549.5M
617.8M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
TECX
RGR
Price
$34.54
$38.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$75.20
$43.00
AVG Volume (30 Days)
182.5K
135.0K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
1.07%
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
N/A
$546,057,000.00
Revenue This Year
N/A
$2.38
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3,869.00
Revenue Growth
N/A
1.94
52 Week Low
$14.39
$28.33
52 Week High
$39.53
$48.21

Technical Indicators

Market Signals
Indicator
TECX
RGR
Relative Strength Index (RSI) 57.62 50.68
Support Level $27.31 $38.60
Resistance Level $35.99 $38.89
Average True Range (ATR) 2.47 0.98
MACD 0.25 0.07
Stochastic Oscillator 50.14 36.12

Price Performance

Historical Comparison
TECX
RGR

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

Share on Social Networks: